BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder

BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder 12/10/2018 HACKENSACK, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) — BrainsWay Ltd. (BRIN.TA), the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain disorders, today announces that the Company’s deep transcranial magnetic…

Achieve TMS East Expands to Chelmsford

By Alana Melanson, amelanson@lowellsun.com UPDATED:   12/09/2018 09:27:26 AM EST   CHELMSFORD — One in six Americans will experience a depressive episode at some point in life, and for a third of them, medication and therapy won’t offer significant relief, according to Dr. Rebecca Knapp. For that subset with treatment-resistant depression, Achieve TMS East offers…